Hansa Biopharma AB (publ) (LON:0RC7)
London
· Delayed Price · Currency is GBP · Price in SEK 22.72
-0.92 (-3.89%)
At close: Feb 21, 2025
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 113.91 million as of February 21, 2025. Its market cap has decreased by -26.19% in one year.
Market Cap
113.91M
Enterprise Value
163.98M
Revenue
12.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.72
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 2.62M to 113.91M, an increase of 4,251.23%. That is a compound annual growth rate of 25.11%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| GSK plc | 58.32B |
| Haleon | 35.36B |
| Smith & Nephew | 9.01B |
| Hikma Pharmaceuticals | 5.12B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.17B |